GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Synthetic MR AB (XSAT:SYNT) » Definitions » Total Liabilities

Synthetic MR AB (XSAT:SYNT) Total Liabilities : kr26.10 Mil (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Synthetic MR AB Total Liabilities?

Synthetic MR AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr26.10 Mil.

Synthetic MR AB's quarterly Total Liabilities increased from Sep. 2023 (kr21.66 Mil) to Dec. 2023 (kr26.39 Mil) but then declined from Dec. 2023 (kr26.39 Mil) to Mar. 2024 (kr26.10 Mil).

Synthetic MR AB's annual Total Liabilities increased from Dec. 2021 (kr14.71 Mil) to Dec. 2022 (kr20.31 Mil) and increased from Dec. 2022 (kr20.31 Mil) to Dec. 2023 (kr26.39 Mil).


Synthetic MR AB Total Liabilities Historical Data

The historical data trend for Synthetic MR AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Synthetic MR AB Total Liabilities Chart

Synthetic MR AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.65 9.64 14.71 20.31 26.39

Synthetic MR AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.39 21.08 21.66 26.39 26.10

Synthetic MR AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Synthetic MR AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=26.158+(0.235+-5.5511151231258E-16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=26.39

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=142.965-116.572
=26.39

Synthetic MR AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=26.055+(0+0.047000000000001
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=26.10

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=146.163-120.061
=26.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Synthetic MR AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Synthetic MR AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Synthetic MR AB (XSAT:SYNT) Business Description

Traded in Other Exchanges
N/A
Address
Storgatan 11, Linkoping, SWE, SE-582 23
Synthetic MR AB develops innovative software solutions for Magnetic Resonance Imaging that supports shorter exam times and delivers more information to the clinician. Its product is available in different packages. SyMRI IMAGE provides high MRI workflows and enables automatic segmentation of brain tissue, providing objective decision support, MAGiC is a customer-specific version of SyMRI IMAGE marketed and sold by GE Healthcare under a licence agreement, SyMRI NEURO includes contrast images, biomarker segmentation, volumetric measurements of brain tissues and quantitative parametric maps, and SyMRI Research Edition includes contrast images, volumetric measurements and quantitative maps to provide more information to the researcher.

Synthetic MR AB (XSAT:SYNT) Headlines

From GuruFocus

Syntel Inc. (SYNT) Chairman, 10% Owner Bharat Desai sells 2,610,000 Shares

By GuruFocus Research GuruFocus Editor 11-22-2010

Interim CEO Invests in IT Company

By Jennifer Chiou Jennifer Chiou 12-07-2016

Insiders Are Investing in Syntel

By Kyle Ferguson Kyle Ferguson 04-27-2017

Syntel: A contrarian's delight

By nicklaskastrup Dhandoisms 05-15-2015

Syntel Inc. Reports Operating Results (10-K)

By gurufocus 10qk 03-03-2011

Syntel Inc. (SYNT) CEO and President Prashant Ranade sells 3,000 Shares

By GuruFocus Research GuruFocus Editor 12-17-2010

Syntel Joins Google Cloud Partner Program

By Marketwired Marketwired 03-26-2018

A Solid Pick at a Fair Price

By Jae Jun Jae Jun 03-31-2015

Syntel Inc.: Value at a Value Price

By MV Research maziume 01-03-2017